![Christoph Huber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christoph Huber
Algemeen Directeur bij
tonestro
Profiel
Christoph Huber was the founder of Ganymed Pharmaceuticals AG, serving as Vice Chairman-Supervisory Board since 2001.
Dr. Huber was the founder of BioNTech SE, serving as Member-Supervisory Board from 2008 to 2023.
Dr. Huber is also the founder of tonestro.
Dr. Huber currently holds the position of Chairman at Association For Cancer Immunotherapy.
Dr. Huber currently holds the position of Deputy Chairman-Supervisory Board at Tirol Kliniken GmbH.
Dr. Huber currently holds the position of Director at Ci3 Management UG.
Dr. Huber currently holds the position of Member-Supervisory Board at AFFiRiS AG since 2015.
Dr. Huber currently holds the position of Advisory Board at Onsight Ventures Management GmbH.
Former positions include Chairman-Hematology & Oncology Department at The Johannes Gutenberg University of Mainz.
Former positions include Member-Supervisory Board at TRON - Translationale Onkologie an der Universitätsmedizin der from 2018 to 2019.
Education includes a doctorate from the University of Innsbruck.
Actieve functies van Christoph Huber
| Bedrijven | Functie | Begin |
|---|---|---|
Association For Cancer Immunotherapy | Voorzitter | - |
Ci3 Management UG | Directeur/Bestuurslid | - |
AFFiRiS AG
 AFFiRiS AG Medical/Nursing ServicesHealth Services Develops and produces vaccines | Directeur/Bestuurslid | 18-05-2015 |
TILAK-Tiroler Landeskrankenanstalten GmbH
 TILAK-Tiroler Landeskrankenanstalten GmbH Hospital/Nursing ManagementHealth Services Operates as a hospital and nursing clinic | Directeur/Bestuurslid | - |
tonestro
 tonestro Packaged SoftwareTechnology Services Operates as an educational application for musical talents to learn, develop and fun | Algemeen Directeur | - |
Onsight Ventures
 Onsight Ventures Investment ManagersFinance Onsight Ventures invests in companies located in Austria. The firm focuses on computing & semiconductors, photonics, advanced additive manufacturing, synthetic biology and digital health sectors. It participates in seed stage capital transactions with an investment size of EUR 0.2 - 1 million. It also makes follow-on investments. | Consultant / Adviseur | - |
Eerdere bekende functies van Christoph Huber
| Bedrijven | Functie | Einde |
|---|---|---|
| BIONTECH SE | Oprichter | 25-05-2023 |
TRON - Translationale Onkologie an der Universitätsmedizin der
 TRON - Translationale Onkologie an der Universitätsmedizin der Miscellaneous Commercial ServicesCommercial Services Operates as biopharmaceutical research organization | Directeur/Bestuurslid | 01-04-2019 |
The Johannes Gutenberg University of Mainz
 The Johannes Gutenberg University of Mainz Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░ | - |
Opleiding van Christoph Huber
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
42
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Ganymed Pharmaceuticals AG
 Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Develops antibodies for the treatment of solid cancers | Health Technology |
University of Innsbruck
 University of Innsbruck Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johannes Gutenberg University of Mainz
The Johannes Gutenberg University of Mainz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AFFiRiS AG
AFFiRiS AG Medical/Nursing ServicesHealth Services Develops and produces vaccines | Health Services |
BioNTech SE
 BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
TILAK-Tiroler Landeskrankenanstalten GmbH
TILAK-Tiroler Landeskrankenanstalten GmbH Hospital/Nursing ManagementHealth Services Operates as a hospital and nursing clinic | Health Services |
Association For Cancer Immunotherapy | |
Ci3 Management UG | |
TRON - Translationale Onkologie an der Universitätsmedizin der
TRON - Translationale Onkologie an der Universitätsmedizin der Miscellaneous Commercial ServicesCommercial Services Operates as biopharmaceutical research organization | Commercial Services |
tonestro
tonestro Packaged SoftwareTechnology Services Operates as an educational application for musical talents to learn, develop and fun | Technology Services |
Onsight Ventures
Onsight Ventures Investment ManagersFinance Onsight Ventures invests in companies located in Austria. The firm focuses on computing & semiconductors, photonics, advanced additive manufacturing, synthetic biology and digital health sectors. It participates in seed stage capital transactions with an investment size of EUR 0.2 - 1 million. It also makes follow-on investments. | Finance |
